The Saudi Food and Drug Authority (SFDA) confirmed on Tuesday that it had not received any reports of cases of blood clots or thrombosis from people who have received COVID-19 vaccines, Saudi Press Agency reported.
The announcement came after reports that some European countries had suspended AstraZeneca vaccine use due to reports of dangerous blood clots in some recipients, though the company and European regulators have said there is no evidence the shot is to blame.
The authority said that it is continuously monitoring the safety of the vaccines available in the Kingdom by studying cases of side effects and the local and international scientific evidence and data available, in coordination with the health and regulatory authorities.
The SFDA also said it was also monitoring the safety of vaccines with manufacturers, the health ministry, and international regulatory bodies through its membership of the International Coalition of Medicines Regulatory Authorities, which includes the World Health Organization and meets periodically to exchange data and information about vaccines.
According to the Health Ministry, more than 2.3 million doses of coronavirus vaccines have been administered in the Kingdom so far.